|
|
Liposomal Doxorubicin Plus IL-12 Effective in AIDS-Related Kaposi Sarcoma
|
| Link ID |
2444 |
| Title |
Liposomal Doxorubicin Plus IL-12 Effective in AIDS-Related Kaposi Sarcoma |
| Url |
http://www.medscape.com/viewarticle/568860?src=rss |
| Description |
Thirty of 36 patients with advanced AIDS-related Kaposi sarcoma treated with cyclical pegylated liposomal doxorubicin plus interleukin-12 (IL-12) had a major response to treatment, according to investigators at the National Cancer Institute in Bethesda, Maryland. Reuters Health Information |
| Category |
Articles > HIV/AIDS |
| Keywords |
|
| Date |
Jan 16, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > HIV/AIDS |
| 1. |
Peripheral Artery Disease Common in HIV Patients
|
|
|
There is a considerably elevated prevalence of peripheral arterial disease (PAD) in HIV-infected patients, Swiss researchers report in the March 1st issue of Clinical Infectious Diseases. Reuters Health Information
|
| 4. |
Simplified Regimen of Ritonavir-Atazanavir Alone May Maintain HIV Suppression
|
|
|
A simplified, two-drug regimen of ritonavir-boosted atazanavir can maintain suppression of HIV replication through 48 weeks of follow-up. The regimen has not been associated with development of protease inhibitor resistance, according to the results of a multicenter study published in the March 15 issue of the Journal of Infectious Disease. Reuters Health Information
|
|
|
